Thinking of joining a study?

Register your interest

NCT05373342 | Not yet recruiting | Surgical Item, Retained


Feasibility Study to Evaluate the Role of a Novel Device in Childbirth
Sponsor:

The Royal Wolverhampton Hospitals NHS Trust

Brief Summary:

Accidentally retained surgical items or swabs are well-recognised errors that result in adverse consequences for patients. This error is one of the commonest "Never Events" - patient safety incidents that are considered preventable. Although uncommon, these incidents can have devastating consequences. Retained surgical items have 70% re-interventions, reaching 80% morbidity and 35% mortality. Swabs or sponges are like small towels that soak up blood and body fluids so that the surgeon can visualise the operating area effectively. Swabs are used in all areas of surgery which include operations on the tummy, chest, limbs. They are also used in the vagina during childbirth, to assess for tears and to minimise blood oozing from the vagina. The common risk factors for this error are out of hours surgical or childbirth procedures, multiple handovers in the care of the patient, raised BMI (Body Mass Index) and unplanned change to the operative intervention. As the name suggests, a 'never event' should never happen in the first place. Never. Unfortunately, this is not the case. Incidents involving surgical swabs being left behind, particularly during a caesarean section or a perineal repair following a vaginal birth, are still happening despite over 100 years of institutional awareness of the problem and tentative solutions being implemented in clinical practice. never-event incidents involving retained surgical swabs are a widespread problem affecting healthcare systems worldwide. It is therefore reasonable to ask the question: why are surgical swabs being left behind and what can be done to prevent this from happening?

Condition or disease

Surgical Item, Retained

Childbirth

Intervention/treatment

iCount system assembled with swabs

Study Type : Observational
Estimated Enrollment : 70 participants
Official Title : Feasibility Study to Evaluate the Role of a Novel Device in the Prevention of Retained Items In Childbirth Environment- Clinical Usability Pilot Study
Actual Study Start Date : June 1, 2024
Estimated Primary Completion Date : December 1, 2024
Estimated Study Completion Date : December 1, 2024

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • Midwifery lead and consultant lead patient older than 18 years.
  • Consented to participation after an informed choice.
Exclusion Criteria
  • • Under 18 years of age
  • Antenatal (before labour)
    • Patients who have a high risk of expected/unexpected maternal, fetal or neonatal deterioration such that during birth, the focus of attention would be towards safe patient care and observation required for using the swab-counter device system would not be possible such as :
    • Patients who are seriously unwell and require high dependency care.
    • Maternal cardiac conditions
    • Severe pre-eclampsia
    • Fetal anomalies where neonatal deterioration is expected (These will be relatively rare conditions where the doctor/midwife would decide to not recruit the patient)
    • Intrapartum and postpartum factors
      • Patient having an emergency Caesarean section instead of a vaginal birth due to maternal or fetal indication.
      • Eclampsia (seizure/fitting in labour or after delivery)
      • Maternal cardiac conditions requiring high dependency care
      • Severe sepsis requiring high dependency care
      • Fetal anomalies where neonatal deterioration is expected

Feasibility Study to Evaluate the Role of a Novel Device in Childbirth

Location Details


Please Choose a site



Feasibility Study to Evaluate the Role of a Novel Device in Childbirth

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Loading...